118 related articles for article (PubMed ID: 429127)
1. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. I. PHA-induced lymphocyte transformation.
Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
Invest Urol; 1979 Mar; 16(5):336-41. PubMed ID: 429127
[TBL] [Abstract][Full Text] [Related]
2. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. II. Immunodepressive effect of sera from bladder carcinoma.
Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
Invest Urol; 1979 Mar; 16(5):342-5. PubMed ID: 429128
[TBL] [Abstract][Full Text] [Related]
3. In vitro immune parameters in relation to clinical course in transitional cell carcinoma.
Cummings KB; Kodera Y; Bean MA
Natl Cancer Inst Monogr; 1978 Dec; (49):119-22. PubMed ID: 155220
[TBL] [Abstract][Full Text] [Related]
4. [Studies of the cellular immune response in patients with urinary bladder carcinoma. X. Evaluation of serum IAP and ASP levels].
Nishio S; Ozaki Y; Wada S; Kawakita J; Maekawa M
Hinyokika Kiyo; 1984 Apr; 30(4):449-57. PubMed ID: 6485956
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
Mizutani Y; Okada Y; Terachi T; Yoshida O
J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
[TBL] [Abstract][Full Text] [Related]
6. Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
Bean MA; Schellhammer PS; Herr HW; Pinsky CM; Whitmore WF
Natl Cancer Inst Monogr; 1978 Dec; (49):111-4. PubMed ID: 155219
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma.
Kastelan Z; Lukac J; Derezić D; Pasini J; Kusić Z; Sosić H; Kastelan M
Anticancer Res; 2003; 23(6D):5185-9. PubMed ID: 14981987
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
[TBL] [Abstract][Full Text] [Related]
9. Studies on nonspecific cellular immune response in patients with urinary bladder carcinoma.
Nishio S; Morikawa Y; Horii A; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
Osaka City Med J; 1978; 24(1):51-71. PubMed ID: 752146
[No Abstract] [Full Text] [Related]
10. [RBC and T lymphocyte subsets in patients with bladder carcinoma: immunological study].
Xu J; Zhang Y
Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):113-6. PubMed ID: 11829798
[TBL] [Abstract][Full Text] [Related]
11. Blood group H antigen in transitional carcinoma of the urinary bladder.
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
[TBL] [Abstract][Full Text] [Related]
12. Correlation of primary tumor bed lymphocytic infiltration and peripheral lymphocyte cytotoxicity in patients with transitional cell carcinoma.
Jones LW; O'Toole C
Natl Cancer Inst Monogr; 1978 Dec; (49):183-5. PubMed ID: 748770
[TBL] [Abstract][Full Text] [Related]
13. [The study of infiltrating lymphocytes in the tissues of bladder carcinoma].
Fujimoto Y; Hasegawa Y; Kato N; Sakai S; Kuriyama M; Kawada Y; Nishiura T; Takeuchi T; Isogai K
Hinyokika Kiyo; 1983 Sep; 29(9):1037-45. PubMed ID: 6610297
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
[TBL] [Abstract][Full Text] [Related]
15. Clinical studies on cell-mediated immunity in patients with urinary bladder carcinoma: blastogenic response, interleukin-2 production and interferon-gamma production of lymphocytes.
Ikemoto S; Kishimoto T; Wada S; Nishio S; Maekawa M
Br J Urol; 1990 Apr; 65(4):333-8. PubMed ID: 2111194
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood lymphocyte subsets in urinary bladder carcinoma patients.
Gaafar T; Lotfy M; el Ridi R
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):511-7. PubMed ID: 1726772
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
[TBL] [Abstract][Full Text] [Related]
18. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients.
Spina CA; Dorey F; Vescera C; Brosman S; Fahey JL
Cancer Res; 1981 Nov; 41(11 Pt 1):4324-30. PubMed ID: 6458353
[TBL] [Abstract][Full Text] [Related]
19. Critical evaluation of lymphocyte functions in urological cancer patients.
Elhilali MM; Paika KD; Brosman S; Fahey JL
Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
[TBL] [Abstract][Full Text] [Related]
20. Clinical status and rate of recovery of blood lymphocyte levels after radiotherapy for bladder cancer.
O'Toole C; Unsgaard B
Cancer Res; 1979 Mar; 39(3):840-3. PubMed ID: 427773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
